(Q57265718)

English

Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C14-erythromycin breath test and the antipyrine clearance test

No description defined

In more languages

Statements

scholarly article

0 references

Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C14-erythromycin breath test and the antipyrine clearance test (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Prudence Francis

object named as

P. Francis

9

0 references

Carleen Cullinane

object named as

C. Cullinane

2

0 references

author name string

M. Michael

1

0 references

A. Hatzimihalis

3

0 references

C. O’Kane

4

0 references

A. Milner

5

0 references

R. Booth

6

0 references

S. Schlicht

7

0 references

S. J. Clarke

8

0 references

publication date

28 May 2011

0 references

Cancer Chemotherapy and Pharmacology

0 references

69

0 references

1

0 references

125-135

0 references

https://scigraph.springernature.com/pub.10.1007/s00280-011-1676-y

0 references

Pharmacogenetic pathway analysis of docetaxel elimination.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Comparative pharmacokinetics of weekly and every-three-weeks docetaxel.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Therapeutic drug monitoring for the individualization of docetaxel dosing: a randomized pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Accuracy and clinical utility of simplified tests of antipyrine metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Dosing strategies for anticancer drugs: the good, the bad and body-surface area

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Effects of uptake and efflux transporter inhibition on erythromycin breath test results

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

The determination of antipyrine elimination in saliva by liquid chromatography.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Population pharmacokinetic model for docetaxel in patients with varying degrees of liver function: incorporating cytochrome P4503A activity measurements

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Pharmacokinetics and toxicity of weekly docetaxel in older patients

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Antipyrine test predicts pharmacodynamics in docetaxel and cisplatin combination chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Clinical pharmacodynamic factors in docetaxel toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

The erythromycin breath test for the prediction of drug clearance

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a)pyrene

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Population pharmacokinetics of weekly docetaxel in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1676-Y

21 January 2018

Identifiers

10.1007/S00280-011-1676-Y

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57265718&oldid=2143605814"